Research Topics
Species | Marie HudsonSummaryAffiliation: McGill University Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlatesKatherine Milette
Department of Psychiatry, McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Rheumatology (Oxford) 49:789-96. 2010....
The validity of administrative data to identify hip fractures is high--a systematic reviewMarie Hudson
Lady Davis Institute for Medical Research, Jewish General Hospital, Room A 725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Clin Epidemiol 66:278-85. 2013..To determine the validity of the diagnostic algorithms for osteoporosis and fractures in administrative data...
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosisMarie Hudson
Division of Rheumatology, Jewish General Hospital, 3755 Cote Ste Catherine, Montréal H3T 1E3, Quebec, Canada
Arthritis Res Ther 14:R50. 2012..We undertook this study to determine the clinical and serologic associations of anti-Ro52/TRIM21 antibodies in patients with systemic sclerosis (SSc)...
Longitudinal study of renal function in systemic sclerosisMelissa Caron
McGill University, Jewish General Hospital, Room A 725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 39:1829-34. 2012..To determine the prevalence of renal disease and the course of renal function over time in patients with systemic sclerosis (SSc)...
Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosisMarie Hudson
Jewish General Hospital, Room A 725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 39:787-94. 2012..To study the clinical phenotypes of centromeric proteins (CENP)-A- and CENP-B-positive patients with systemic sclerosis (SSc) and to compare them to anticentromere antibody (ACA)-positive and negative SSc patients...
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analysesWilliam G Dixon
Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, Stopford Building, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK
Arthritis Res Ther 13:R139. 2011..The objective of this study was to perform a systematic review and meta-analysis of the effect of glucocorticoid (GC) therapy on the risk of infection in patients with RA...
Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosisM Hudson
McGill University, Montreal, Quebec, Canada
Clin Exp Rheumatol 25:754-7. 2007....
Hypocomplementemia in systemic sclerosis--clinical and serological correlationsMarie Hudson
SMBD Jewish General Hospital and McGill University, 3755 Cote Sainte Catherine Road, Montreal, Quebec, Canada
J Rheumatol 34:2218-23. 2007..We hypothesized that hypocomplementemia in SSc might indicate the presence of overlap disease. We investigated if SSc patients with hypocomplementemia had more features of overlap disease than those with normal complement levels...
Patients with systemic autoimmune diseases could not distinguish comorbidities from their index diseaseMarie Hudson
McGill University, Montreal, Quebec, Canada
J Clin Epidemiol 61:654-62. 2008..To assess the construct validity of the Self-Administered Comorbidity Questionnaire (SCQ) in patients with systemic sclerosis (SSc) and systemic lupus erythematosus (SLE)...
Modeling smoking in systemic sclerosis: a comparison of different statistical approachesMarie Hudson
Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 63:570-8. 2011..To determine the effect of different methods of modeling smoking on vascular outcomes in rheumatic diseases...
Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditionsMarie Hudson
SMBD Jewish General Hospital and McGill University, Room A 216, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 36:768-72. 2009..We compared the HRQOL of SSc patients with individuals in the general population and patients with other common chronic diseases...
Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule IIMarie Hudson
Sir Mortimer B Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 59:270-8. 2008..To determine the validity of the World Health Organization Disability Assessment Schedule II (WHODAS II) in systemic sclerosis (SSc)...
Time to diagnosis in systemic sclerosis: is sex a factor?Marie Hudson
Sir Mortimer B Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 61:274-8. 2009..To determine whether sex plays a role in the time to diagnosis of systemic sclerosis (SSc)...
Clinical correlates of self-reported physical health status in systemic sclerosisMarie Hudson
SMBD Jewish General Hospital and McGill University, Room A 216, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 36:1226-9. 2009..Our objective was to identify the clinical characteristics that correlate with the physical health status of patients with SSc, as assessed by the Medical Outcomes Trust Short Form-36 (SF-36)...
Validity of self-reported comorbidities in systemic sclerosisMarie Hudson
Sir Mortimer B Davis Jewish General Hospital and McGill University, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 36:1477-80. 2009..To assess the validity of self-reports by patients with systemic sclerosis (SSc) of 5 common, chronic conditions (hypertension, diabetes, cancer, depression, and osteoarthritis/back pain) as compared to chart review...
Discordance between patient and physician assessments of disease severity in systemic sclerosisMarie Hudson
Jewish General Hospital, Room A 725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 37:2307-12. 2010..To describe the magnitude and correlates of discordance between patient and physician assessments of disease severity in patients with systemic sclerosis (SSc)...
Health-related quality of life in systemic sclerosis: a systematic reviewMarie Hudson
SMBD Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 61:1112-20. 2009..The objective of this study was to systematically review the literature on HRQOL in SSc measured using the Medical Outcomes Trust Short Form 36 (SF-36)...
Work disability in systemic sclerosisMarie Hudson
Sir Mortimer B Davis Jewish General Hospital and McGill University, Quebec, Canada
J Rheumatol 36:2481-6. 2009..Little is known about work disability in SSc. We undertook this study to determine the prevalence and demographic and clinical correlates of work disability in a large cohort of patients with SSc...
Systemic sclerosis: establishing diagnostic criteriaMarie Hudson
Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Medicine (Baltimore) 89:159-65. 2010..We conclude that important diagnostic clues in patients with SSc include Raynaud phenomenon, skin involvement, clinically visible mat-like telangiectasias, and SSc-related autoantibodies...
Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosisM Hudson
Division of Rheumatology, Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Clin Exp Rheumatol 28:S36-41. 2010..To determine intra- and inter-observer reliability of widefield microscopy to measure nailfold capillary density in patients with systemic sclerosis (SSc)...
Cigarette smoking in patients with systemic sclerosisMarie Hudson
SMBD Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 63:230-8. 2011..To determine the effects of cigarette smoking on vascular, gastrointestinal, and respiratory outcomes in patients with systemic sclerosis (SSc)...
Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?Marie Hudson
The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Arthritis Rheum 57:516-23. 2007..Nonsteroidal antiinflammatory drugs (NSAIDs) as a class have been shown to increase the risk of congestive heart failure (CHF) compared with celecoxib. The magnitude of the risk for individual NSAIDs is not known...
Update on indices of disease activity in systemic sclerosisMarie Hudson
Division of Rheumatology, McGill University, Montreal, Canada
Semin Arthritis Rheum 37:93-8. 2007..An important barrier in the study of systemic sclerosis (SSc) is the difficulty in measuring disease activity. We reviewed the literature on currently available global measures of disease activity in SSc...
Comparison of measures of medication persistency using a prescription drug databaseMarie Hudson
Division of Clinical Epidemiology, The Research Institute of the McGill University Health Center, Montreal, Quebec, Canada
Am Heart J 153:59-65. 2007..We undertook a study of persistency to statins using various definitions to compare the results obtained with the different definitions...
Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?Marie Hudson
Division of Clinical Epidemiology, The Research Institute of the McGill University Health Center, 687 Pine Avenue West, Building V, Montreal, Quebec, Canada
Pharmacoepidemiol Drug Saf 16:773-85. 2007....
Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population studyMarie Hudson
Division of Clinical Epidemiology, The Research Institute of the McGill University Health Centre, 1650 Cedar Ave, Montreal, QC, Canada
Eur J Heart Fail 9:602-9. 2007..We wish to determine whether there are sex-related differences in the optimal treatment of congestive heart failure...
Angiotensin II receptor blockers for the treatment of heart failure: a class effect?Marie Hudson
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec
Pharmacotherapy 27:526-34. 2007..To examine the class effect of angiotensin II receptor blockers (ARBs) on mortality in patients with heart failure who were aged 65 years or older...
Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patientsBrett D Thombs
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Rheum 61:966-73. 2009..To assess fatigue levels and demographic, socioeconomic, disease, and psychosocial correlates of fatigue in patients with systemic sclerosis (SSc)...
Prevalence and clinical correlates of pruritus in patients with systemic sclerosisIlya Razykov
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Rheum 61:1765-70. 2009..The objectives of this study were to document the proportion of SSc patients with pruritus on most days, to determine when in the course of the disease pruritus is most prevalent, and to identify clinical correlates...
Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigmMurray Baron
SMBD Jewish General Hospital, Room A 216, 3755 Cote Ste Catherine Road, Montreal, Quebec, H3T 1E2, Canada
J Am Coll Nutr 29:144-51. 2010..Malnutrition is common in many chronic diseases, but physicians may rely on a low albumin value before deciding that malnutrition is present...
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosisOrit Schieir
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 62:409-17. 2010..The present study estimated prevalence, severity, and associations between SSc clinical variables and pain in all patients with SSc and in limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) subsets...
Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidenceMarc Bardou
Division of Gastroenterology, Department of Medicine, McGill University and McGill University Health Center, Montreal, Quebec, Canada
Clin Gastroenterol Hepatol 2:880-7. 2004..We investigated the effects of the selective cyclooxygenase 2 inhibitors (coxibs), rofecoxib and celecoxib, the nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin on esophageal cancer...
Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosisBrett D Thombs
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Rheum 59:438-43. 2008..Our objective was to assess the internal consistency reliability, convergent validity, and structural/construct validity of the Center for Epidemiologic Studies Depression Scale (CES-D) in patients with SSc...
Association of pruritus with quality of life and disability in systemic sclerosisGhassan El-Baalbaki
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 62:1489-95. 2010..The objective of this study was to investigate the association of pruritus with QOL and disability in SSc...
Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group databaseMurray Baron
SMBD Jewish General Hospital and McGill University, Montreal, Quebec, Canada
J Rheumatol 36:2737-43. 2009..Little is known about nutritional status in SSc. We investigated the prevalence and demographic and clinical correlates of nutritional status in a large cohort of patients with SSc...
Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule IIMarie Hudson
Sir Mortimer B Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 59:279-84. 2008....
The cost of systemic sclerosisSasha Bernatsky
McGill University, Montreal, Quebec, Canada
Arthritis Rheum 61:119-23. 2009..To assess costs related to systemic sclerosis (SSc) and their determinants...
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosisBrett D Thombs
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Rheum 59:504-9. 2008..To assess the prevalence and predictors of symptoms of depression in a large sample of patients with systemic sclerosis (SSc)...
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National SurveyMarielle Bassel
Jewish General Hospital, Department of Psychiatry, Montreal, Quebec H3T 1E4, Canada
Rheumatology (Oxford) 50:762-7. 2011..The objective of the present study was to identify symptoms of SSc that patients rated as frequent and that highly impacted their ability to carry out daily activities...
Healthcare costs of inflammatory myopathiesSasha Bernatsky
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, 687 Pine Avenue West, Montreal, Quebec, Canada
J Rheumatol 38:885-8. 2011..Little information exists regarding the economic burden related to inflammatory myopathies. Our objective was to estimate health services costs in a large, unselected, population-based sample of patients with inflammatory myopathies...
Demographic and clinical factors associated with physician service use in systemic sclerosisSasha Bernatsky
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, 687 Pine Avenue West, V Building, Montreal, Quebec, Canada, H3A 1A1
J Rheumatol 36:96-8. 2009..To assess physician service use in a large sample of patients with systemic sclerosis (SSc), and to determine factors associated with physician use...
High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptomsBrett D Thombs
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Rheum 59:431-7. 2008..The objective of this study was to assess whether these high rates result from differential reporting of somatic symptoms related to the high physical burden of SSc...
Disability in systemic sclerosis -- a longitudinal observational studyMireille Schnitzer
Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 38:685-92. 2011..To assess disability in systemic sclerosis (SSc) longitudinally and to identify disease-specific determinants, after accounting for informative patient dropout...
Clinical correlates of sleep problems in systemic sclerosis: the prominent role of painKatherine Milette
Department of Psychiatry, McGill University, Montreal, Quebec, Canada
Rheumatology (Oxford) 50:921-5. 2011..Little research, however, has examined factors associated with sleep disruption in SSc. Therefore, the objective of this study was to investigate socio-demographic and medical factors associated with sleep disruption in SSc...
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based studyMarie Hudson
Division of Clinical Epidemiology, Research Institute of McGill University Health Center, 1650 Cedar Avenue, Montreal, QC, H3G 1A4 Canada
BMJ 330:1370. 2005..CONCLUSIONS: Celecoxib seems safer than rofecoxib and NSAIDs in elderly patients with congestive heart failure. Differences were found among cyclo-oxygenase-2 inhibitors...
Assessment of reproductive history in systemic sclerosisSasha Bernatsky
McGill University, Montreal, Quebec, Canada
Arthritis Rheum 59:1661-4. 2008..To assess the number of live births in women whose systemic sclerosis (SSc) onset occurred during their reproductive years, and to compare this with general population rates...
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritisMurray Baron
McGill University, Montreal, Quebec, Canada
Arthritis Rheum 59:382-90. 2008..To assess the clinimetric properties of a new health-related quality of life (HRQOL) instrument, the World Health Organization Disability Assessment Schedule II (WHODAS II), in patients with early inflammatory arthritis...
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancerElham Rahme
Division of Clinical Epidemiology, McGill University Health Centre Research Institute, Montreal, Canada
BMC Cancer 5:159. 2005..The cyclooxygenase (COX)-2 enzyme is expressed more in breast cancers than in normal breast tissue. COX-2 inhibition may have a role in breast cancer prevention...
Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosisMurray Baron
SMBD Jewish General Hospital, Room A 725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada
J Rheumatol 38:1925-30. 2011..Our study assesses the internal consistency and validity of the instrument in a different population than was used in the original study...
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarctionMarie Hudson
Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada
J Rheumatol 32:1589-93. 2005..There may be differences in the risk of heart disease with various NSAID...
Antirheumatic drug use and the risk of acute myocardial infarctionSamy Suissa
McGill University Health Centre, Montreal, Canada
Arthritis Rheum 55:531-6. 2006..To assess the risk of acute myocardial infarction (AMI) associated with the use of disease-modifying antirheumatic drugs (DMARDs) and other medications commonly used in rheumatoid arthritis (RA)...
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaireMurray Baron
Division of Rheumatology, Sir Mortimer B Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada
Rheumatology (Oxford) 48:390-4. 2009..To adapt the self-administered comorbidity questionnaire (SCQ) into the Early Inflammatory Arthritis-SCQ (EIA-SCQ) and assess its clinimetric properties in EIA...
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosisRussell Steele
Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 64:519-24. 2012..To develop a clinical decision rule to predict the presence of interstitial lung disease (ILD) in systemic sclerosis (SSc; scleroderma) and to estimate the prevalence of SSc-ILD...
Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scaleDaphna Harel
Department of Mathematics and Statistics, McGill University, Montreal, Quebec, Canada
Rheumatology (Oxford) 51:2177-85. 2012..The objective of this study was to compare the performances of the Short Form-36 (SF-36) Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT) in SSc...
Measuring pain in systemic sclerosis: comparison of the short-form McGill Pain Questionnaire versus a single-item measure of painGhassan El-Baalbaki
Department of Psychiatry, McGill University, Montreal, Quebec, Canada
J Rheumatol 38:2581-7. 2011....
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary diseaseSamy Suissa
Division of Clinical Epidemiology, McGill University Health Centre, Canada
Pulm Pharmacol Ther 21:234-8. 2008..TNF-alpha may be important in the pathogenesis of COPD. Consequently, the use of TNF-alpha antagonists has been advocated for its treatment...
Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sampleAllison Leavens
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 64:1195-201. 2012..The objective was to assess whether SSc patients had higher somatic symptom scores on the PHQ-9 than non-medically ill respondents from the general population matched on cognitive/affective scores...
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs
Jewish General Hospital, Montreal, Quebec, Canada
Clin Exp Rheumatol 30:S23-9. 2012..The goal of SPIN, as described in this article, is to develop, test, and disseminate a set of accessible interventions designed to complement standard care in order to improve HRQoL outcomes in SSc...
Sociodemographic and disease correlates of body image distress among patients with systemic sclerosisLisa R Jewett
Department of Psychiatry, McGill University, Montreal, Quebec, Canada
PLoS ONE 7:e33281. 2012..The objective of this study was to identify sociodemographic and disease-related correlates of dissatisfaction with appearance and social discomfort among people with SSc...
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritisSamy Suissa
McGill University Health Centre, Montreal, Quebec, Canada
Arthritis Rheum 54:1435-9. 2006..To assess this risk, we conducted a population-based epidemiologic study...
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosisLisa R Jewett
McGill University and Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 62:1779-86. 2010..The objective was to develop and cross-validate a brief version of the Satisfaction with Appearance Scale (SWAP) in order to reduce item redundancy, increase SSc relevancy, and improve the feasibility of body image assessment in SSc...
Office capillaroscopy in systemic sclerosisMurray Baron
McGill University, and Jewish General Hospital, Montreal, Quebec, Canada
Clin Rheumatol 26:1268-74. 2007..The ophthalmoscope is valid when compared to the microscope for detecting giant or dilated capillaries. We conclude that these techniques are useful office tools to detect capillary abnormalities in SSc...
Rates and correlates of sexual activity and impairment among women with systemic sclerosisBrooke Levis
McGill University and Jewish General Hospital, Montreal, Quebec, Canada
Arthritis Care Res (Hoboken) 64:340-50. 2012....
Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung diseaseMarianna M Newkirk
Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Eur J Immunol 42:1051-61. 2012..Identification of these autoantibodies could suggest a common environmental insult, namely CS, in a number of different disease settings...
Combined oral contraceptive use and the risk of systemic lupus erythematosusMarie Odile Bernier
McGill Pharmacoepidemiology Research Unit, McGill University, Montreal, Quebec, Canada
Arthritis Rheum 61:476-81. 2009....
Medication use in systemic lupus erythematosusSasha Bernatsky
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, 687 Pine Avenue West, V Building, V2 09, Montreal, Quebec H3A 1A1, Canada
J Rheumatol 38:271-4. 2011..To evaluate factors affecting therapeutic approaches used in clinical practice for the management of systemic lupus erythematosus (SLE), in a multicenter cohort...
Depression in patients with systemic sclerosis: a systematic review of the evidenceBrett D Thombs
Sir Mortimer B Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Arthritis Rheum 57:1089-97. 2007..To assess the prevalence, course, and predictors of depression in patients with systemic sclerosis (SSc)...
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodiesMarie Hudson
Division of Rheumatology, McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada
J Rheumatol 30:2385-91. 2003....
Polyautoimmunity and familial autoimmunity in systemic sclerosisMarie Hudson
SMBD Jewish General Hospital and McGill University, Montreal, Canada
J Autoimmun 31:156-9. 2008..Clinically different autoimmune phenotypes might share common susceptibility variants, which acting in epistatic pleiotropy may represent risk factors for autoimmunity...
Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panelMurray Baron
Jewish General Hospital and McGill University, Montreal, Canada
Clin Exp Rheumatol 28:S42-6. 2010..To develop a set of recommendations for clinicians caring for patients with systemic sclerosis (SSc) to guide their approach to the patient with malnutrition and possible malabsorption...
(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samplesRuby Knafo
Department of Psychiatry, McGill University and General Hospital, Montreal, Quebec, Canada
Rheumatology (Oxford) 48:1300-3. 2009..The objective of this study was to compare levels of sexual impairment in women with SSc with samples of women with medical illnesses for which sexual impairment has been researched more extensively...
Scleroderma prevalence: demographic variations in a population-based sampleS Bernatsky
Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada
Arthritis Rheum 61:400-4. 2009..To estimate the prevalence of systemic sclerosis (SSc) using population-based administrative data, and to assess the sensitivity of case ascertainment approaches...
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritisS Bernatsky
Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec H3A 1A1, Canada
Rheumatology (Oxford) 46:1157-60. 2007..To assess the risk of severe infections associated with the use of traditional disease-modifying anti-rheumatic drugs (DMARDs) and glucocorticoid agents in rheumatoid arthritis (RA)...
Identifying target areas of treatment for depressed early inflammatory arthritis patientsPatricia L Dobkin
Department of Medicine, McGill University, Montreal, Que, Canada
Psychother Psychosom 77:298-305. 2008..The goal of this study was to identify target areas for psychosocial intervention for depressed patients with early inflammatory arthritis...
The relationship of dyspnoea to function and quality of life in systemic sclerosisM Baron
McGill University, Montreal, Quebec, Canada
Ann Rheum Dis 67:644-50. 2008....
Surveillance of systemic autoimmune rheumatic diseases using administrative dataS Bernatsky
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, 687 Pine Avenue West, V Building, V2 09, Montreal, QC H3A 1A1, Canada
Rheumatol Int 31:549-54. 2011..Our results suggest that surveillance of some rheumatic diseases using administrative data may indeed be feasible. Our work highlights the usefulness of using multiple data sources, adjusting for the error in each...
A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samplesB D Thombs
Department of Psychiatry, McGill University and Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Rheumatology (Oxford) 47:1559-63. 2008..The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively...
Reports of abnormal cervical cancer screening tests in systemic sclerosisS Bernatsky
Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, 687 Pine Avenue West, V Building, Montreal, Quebec H3A1A1, Canada
Rheumatology (Oxford) 48:149-51. 2009..To assess the prevalence of abnormal cervical cancer screening (Pap tests) reported by women with SSc onset before the age of 50 yrs...
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritisSamy Suissa
Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Canada
Am J Med 117:87-92. 2004..We assessed the risk of hepatic events associated with the use of leflunomide and other DMARDs...
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritisS Bernatsky
Division of Clinical Epidemiology, Montreal General Hospital, Canada
Rheumatology (Oxford) 44:677-80. 2005..The increased risk with rofecoxib alongside a decreased risk with celecoxib suggests the absence of a class effect with respect to COX-II inhibitors for some types of cardiovascular morbidity...
Corticosteroids and the risk of scleroderma renal crisis: a systematic reviewGerald Trang
McGill University, Room A 216, 3755 Côte Ste Catherine Street, Montreal, QC, H3T 1E2, Canada
Rheumatol Int 32:645-53. 2012..Great caution must continue to be exerted when initiating such therapy, especially in high doses and in the early diffuse subset of SSc patients...
The development of systemic sclerosis classification criteriaJennifer G Walker
Faculty of Medicine, University of Calgary, 3330 Hospital Dr NW, T2N 4N1, Calgary, AB, Canada
Clin Rheumatol 26:1401-9. 2007..Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread...
Missing data in rheumatologic studies and the practical reality of modern approaches to the analysis of incomplete subject data: comment on the article by Baron et al and the editorial by BoersRussell Steele
Arthritis Rheum 59:1367-8. 2008
Antibodies to RNA polymerase III in systemic sclerosis detected by ELISAMittermayer Santiago
Servico de Reumatologia do Hospital do Santa Izabel, Escola Bahiana de Medicina e Saude Publica, Salvador, Brazil
J Rheumatol 34:1528-34. 2007..To determine serological and clinical variables associated with anti-RNA polymerase III (RNAP-III) antibodies in patients with systemic sclerosis (SSc) using a new ELISA method...
Are the Short Form 36 physical and mental component summary scores useful measures in patients with systemic sclerosis? Comment on the article by Rannou et alMarie Hudson
Arthritis Rheum 57:1339; author reply 1339-40. 2007

